Could the changes of immunity induced by SARS-CoV-2 infections explain the rebound of infectious disease after the relaxation of non-pharmaceutical interventions?

Infect Dis Now. 2024 Feb;54(1):104836. doi: 10.1016/j.idnow.2023.104836. Epub 2023 Nov 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Testing
  • COVID-19*
  • Communicable Diseases*
  • Humans
  • SARS-CoV-2